rivaroxaban has been researched along with Cytokine-Release-Syndrome* in 1 studies
1 other study(ies) available for rivaroxaban and Cytokine-Release-Syndrome
| Article | Year |
|---|---|
Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.
We report 3 patients with coronavirus disease who had a decline in respiratory status during their hospital course that responded well to intravenous steroids and interleukin-6 receptor antagonist therapy. These patients later showed development of persistent hypoxia with increased levels of d-dimer levels and were given a diagnosis of pulmonary embolisms. Topics: Acute Disease; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Betacoronavirus; Biomarkers; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Cytokine Release Syndrome; Enoxaparin; Female; Fibrin Fibrinogen Degradation Products; Humans; Hypoxia; Male; Methylprednisolone Hemisuccinate; Middle Aged; Pandemics; Pneumonia, Viral; Pulmonary Embolism; Rivaroxaban; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |